Literature DB >> 23671271

Therapeutic effect of probiotic dahi on plasma, aortic, and hepatic lipid profile of hypercholesterolemic rats.

Dheeraj Mohania1, Vinod Kumar Kansal, Dilip Shah, Ravinder Nagpal, Manoj Kumar, Sanjeev Kumar Gautam, Birbal Singh, Pradip Vishnu Behare.   

Abstract

This study examined the effects of probiotic dahi prepared by Lactobacillus plantarum Lp9 and dahi culture in buffalo milk on lowering cholesterol in rats fed a hypercholesterolemic basal diet. Male Wistar rats were divided into 3 groups and fed with probiotic dahi, dahi, or buffalo milk for 120 days. Following the consumption of supplements (probiotic dahi, dahi or buffalo milk), the animals were fed a basal hypercholesterolemic diet. Plasma total cholesterol and triglycerides (TAGs) were decreased by 35% and 72% in rats fed with probiotic dahi group, while cholesterol levels increased by 70% and TAGs increased by 97% in buffalo milk and 59% in dahi fed groups. Supplementation of probiotic dahi further lowered plasma low-density lipoprotein (LDL) + very-low-density lipoprotein (VLDL)- cholesterol by 59%, while it elevated plasma high-density lipoprotein (HDL)-cholesterol by 116%. As a result, atherogenic index, the ratio of HDL to LDL + VLDL was markedly improved. Deposition of cholesterol and TAGs in liver and aorta were significantly reduced in rats fed with probiotic dahi. These observations suggest that probiotic dahi may have therapeutic potential to decrease plasma, hepatic and aortic lipid profile, and attenuate diet-induced hypercholesterolemia.

Entities:  

Keywords:  Lactobacillus plantarum; cardiovascular disease; probiotics

Mesh:

Substances:

Year:  2013        PMID: 23671271     DOI: 10.1177/1074248413487431

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  6 in total

Review 1.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

2.  Serum Intestinal Metabolites are Raised in Patients with Psoriasis and Metabolic Syndrome.

Authors:  Liyun Sun; Xinwei Guo; Yeping Qin; Ping Li; Chunxia Yu; Xuesong Gao; Xinran Xie; Xuying Xu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-05-13

3.  Beneficial Properties of Probiotics.

Authors:  Lye Huey Shi; Kunasundari Balakrishnan; Kokila Thiagarajah; Nor Ismaliza Mohd Ismail; Ooi Shao Yin
Journal:  Trop Life Sci Res       Date:  2016-08

Review 4.  Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics.

Authors:  Mingqian He; Bingyin Shi
Journal:  Cell Biosci       Date:  2017-10-25       Impact factor: 7.133

Review 5.  The role of intestinal microbiota in cardiovascular disease.

Authors:  Mengchao Jin; Zhiyuan Qian; Jiayu Yin; Weiting Xu; Xiang Zhou
Journal:  J Cell Mol Med       Date:  2019-02-03       Impact factor: 5.310

6.  Variations in fatty acid and amino acid profiles of doi and rasomalai made from buffalo milk.

Authors:  Abu Hena Md Asif; Gautam Kumar Deb; Md Rezwanul Habib; Md Harun-Ur-Rashid; Md Abid Hasan Sarker; Umma Fatema Shahjadee; Sharmin Akter Lisa; Salma Ahmed; Dag Ekeberg; Einar Vargas-Bello-Pérez; Mohammad Ashiqul Islam
Journal:  J Adv Vet Anim Res       Date:  2021-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.